11-100 Bessemer Road, London, Ontario, Canada, N6E 1R2 | 289-903-3127
CONFIDENTIALITY & NON-DISCLOSURE AGREEMENT
​
By accessing this Data Room, viewing its content and/or downloading the attached materials (The "Evaluation Material"), you agree to the following terms with Bizbio Inc. (the "Company"):
​
-
Confidentiality: You acknowledge that the Evaluation Material contains proprietary trade secrets, financial data, and intellectual property, specifically regarding US Patent Application No. 63/925,839 (Priority Date: Nov 26, 2025) and the "Comedy Compass™" protocols.
-
Use Limitation: You agree to use this material solely for the purpose of evaluating a potential investment in the Company.
-
No License: Nothing in these documents grants you any license or right to the Intellectual Property, "Active Interrogation" technology, or "Agentic Defense" mechanisms described therein.
-
Non-Disclosure: You will not disclose, share, or publish any portion of these materials to third parties without the Company’s prior written consent.
"I do not like that man. I must get to know him better." - Abraham Lincoln
CONFIDENTIAL DATA ROOM
Authorized Access Only. Proprietary IP of Bizbio Inc.
For documentation including specifications of our patent-pending technology, granular financial modeling, technical patent diagrams, and the "Agentic Commerce" deep dive, visit DocSend Secure Server by clicking below.
S2 - Bizbio Inc. Presents: BLUEPRINT | An Investment Thesis
S2 - Bizbio Inc. Presents: BLUEPRINT | An Investment Thesis
Newsload App | Investor Demonstration
Executive Summary: The Pitch Deconstructed
Strategic Roadmap: From Fortress to Global Scale
Don't have time to read the full brief? Listen to this AI-generated, podcast like, conversational breakdown of the Investment Thesis, Patent Strategy, and Valuation Model.